Azeemuddin Ahmed, MD, MBA is a Clinical Professor of Emergency Medicine and Adjunct Clinical Professor of Management and Entrepreneurship at the University of Iowa. He practices and teaches Emergency Medicine at the University of Iowa Carver College of Medicine and the University of Iowa Hospitals and Clinics. Serving as Executive Vice Chair, he works closely with the department chair in all aspects of departmental administration with added focus on faculty recruitment, faculty development, faculty practice plan, faculty compensation, clinical innovation as well as strategic planning. Dr. Ahmed is board certified in Emergency Medicine and sub-specialty board certified in Emergency Medical Services by the American Board of Emergency Medicine.

His area of clinical expertise is pre-hospital care, and Dr. Ahmed serves as the Division and Fellowship Program Director for Emergency Medical Services in the Department of Emergency Medicine. In the realm of medical direction, he is Medical Director of Kinnick Stadium and Carver Hawkeye Arena as well as the Medical Director for the Bureau of Emergency Medical and Trauma Services, Iowa Department of Health and Human Services. Dr. Ahmed is an active researcher with projects involving health services, pre-hospital care, and continues to publish case reports, book chapters, research abstracts and manuscripts in a variety of academic media. He presents didactic lectures both locally and nationally and is a member of several professional organizations devoted to the advancement of Emergency Medicine care, education and research. He has received numerous teaching awards from his trainees in recognition of his education efforts.

Dr. Ahmed brings his education, enthusiasm, and real-world experience in conducting negotiations to the Dynamics of Negotiations class at the University of Iowa Tippie College of Business. He has proficiency in negotiating in a variety of situations within the health care system, between organizational units, human resources and business development. He provides seminars on negotiation strategies and tactics to a variety of business and health care organizations regionally and nationally. He was recognized by the Tippie Executive MBA – Iowa City Classes of 2015, 2018, 2019 and 2020 as a GREAT Instructor of the Year. In 2017, Dr. Ahmed was selected by the Tippie Executive MBA – Des Moines cohort as a GREAT Instructor of the Year and they also nominated him for the President and Provost Teaching Award.

In his free time, Dr. Ahmed is an endurance athlete having completed 21 half marathons and 5 marathons (including the New York City Marathon).

Dr. Shooshan Danagoulian is an associate professor of economics at Wayne State University. As a health economist, Dr. Danagoulian’s research focuses on health insurance utilization and delivery of care, emergency department care and environmental health outcomes.

Dr. S. Eliza Dunn (Halcomb) is an emergency medicine physician and medical toxicologist with a long-
standing interest in global health.

After completing her toxicology fellowship at NYU in 2006, Dr. Dunn returned to Washington University
in St. Louis and started an ACGME accredited fellowship in Medical Toxicology.
Over the following ten years, Dr. Dunn became increasingly involved with global health and
humanitarian relief projects. She organized a relief mission to Haiti after the 2010 earthquake, started
the scholar track in Global Health for the Washington University Division of Emergency Medicine, and is
one of the Global Health Scholars for the Department of Internal Medicine.

Over the years, Dr. Dunn began to realize that in order to have a sustainable impact in global health,
there needed to be an effort to focus on creative ways of addressing malnutrition and insect-borne
illness, two of the most commonly encountered public health problems in developing countries. With
that in mind, Dr. Dunn started working as the Medical Affairs Lead for Bayer, a global seed and chemical
company with innovative technology that has great potential to remediate malnutrition.

Dr. Dunn has lectured nationally and internationally on a diverse range of topics in medical toxicology
and global health.

Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

Dr. Ashley Haynes completed her medical training at the University of Kansas, followed by a combined emergency-internal medicine training program at East Carolina University.  She completed a toxicology fellowship at University of Texas Southwestern in 2016, remaining as faculty for a few years after while engaging in a faculty development project in addiction medicine.  She moved to Kansas in 2019 and now provides bedside toxicology and addiction medicine consultations at Ascension Via Christi hospitals in Wichita and periodically provides on-call support for the Kansas Poison Control Center.  Additionally, she is a program physician for an outpatient addiction treatment center, and provides medication assisted therapy services to an inpatient residential treatment facility.

I am a board-certified Medical Toxicologist, Addictionologist, and Emergency Medicine physician. I completed my residency at Memorial Hospital in York, PA. My fellowship was completed at Virginia Commonwealth University in Richmond, VA. I currently work at WellSpan York Hospital in York, PA, as an Emergency Physician, Medical Toxicologist, and working with in-patients starting treatment for addiction. I initiated the toxicology service at York Hospital and now I am the Medical Director for Medical Toxicology. I am interested in treating the poisoned patients at bedside, and especially interested in the antidotal therapy with physostigmine (if it returns) and flumazenil. I enjoy professional engagement with ACMT.

I am a currently Adjunct Clinical Professor on the Division of Environmental and Occupational Health Sciences and the Occupational and Environmental Medicine Service of UI Health at the University of Illinois at Chicago and Professor of Medicine at Rosalind Franklin University of Medicine & Science in North Chicago, Ill.

In 1980, I received my medical degree from the Chicago Medical School.  I then completed a combined residency in Internal Medicine and Emergency Medicine at Northwestern University (1984) followed by a three-year preceptorship/fellowship training in Medical Toxicology at Cook County Hospital and University of Illinois Hospital in Chicago, Illinois. I am Board Certified in Internal Medicine, Emergency Medicine, Medical Toxicology and Addiction Medicine. 

I served as the Associate Director of the Emergency Department at Rush Presbyterian-St. Luke’s Medical Center in Chicago from 1998-2001.  During this time, I was also the Medical Director of the Rush Poison Control Center and served as Medical Director of the United States Drug Testing Laboratory (from 1991 -1996).  I was also the Medical Director of PROSAR (located in St. Paul, MN); a national call center devoted to industrial exposures and product safety issues, up until December 2013.

I have presented over 200 research abstracts at national meetings (primarily to the North American Congress of Clinical Toxicology) and have published over 200 articles in peer-reviewed medical journals.  I am the co-editor of the Poisoning and Toxicology Handbook (now in its fourth edition), published by CRC Press, and the American Medical Association Handbook of First Aid and Emergency Care, and published by Random House (New York).  I am also the co-editor with Dr. Robin McFee for the Toxico-terrorism book (McGraw Hill) and the Handbook of Nuclear, Biological and Chemical Agent Exposure (CRC Press) both published in 2007.  I was also the co-editor of the American Medical Association Complete Medical Encyclopedia, published by Random House in 2003.  I am presently the Editor-in-Chief of the primary care journal, Disease-a-Month, published by Elsevier.  I was on the Illinois State Board of Health from 2016 – 2019.

Dr. Nanagas graduated from The Ohio State University School of Medicine and Public Health in 1999 before completing her Emergency Medicine residency at Methodist/Indiana University in 2002. She was inspired to do the Medical Toxicology fellowship (also at IU) after her resident rotation on the toxicology service. After negotiating cat visitation rights in exchange for cooperation with medical therapy from a particularly difficult patient and learning a whole new vocabulary of swear words from her colorful patients that month, she knew this was the specialty for her. She completed her Medical Toxicology fellowship in 2004 and has been a member of the IUSOM faculty since then. In addition to working in the IUH Methodist Emergency Department, she is the Division Chief for Medical Toxicology.  The Medical Toxicology consult service performs inpatient consults at the IUH Academic Health Center, the Riley Hospital for Children, and Eskenazi Health, in addition to providing medical backup for the Indiana Poison Center.  Her interests include clinical operations, deprescribing, and mentoring.  Her scholarly work focuses on the care of poisoned patients. Kris dearly loves her husband and three children- who all relish living near Eagle Creek Park and enjoying the outdoors there. She shares her home with numerous animals- some of whom are invited and some are merely invading and hard to eradicate.

Dr. Anthony (Tony) Pizon received his medical degree from the University of Toledo School of Medicine in 2001.  He then completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and his Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is currently a Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Chief of the Division of Medical Toxicology and Director of the Medical Toxicology Fellowship at UPMC. He is also Assistant Medical Director of both the Pittsburgh and West Virginia Poison Centers. Yet, most importantly, he is blessed with amazing wife, Caryn, and four wonderful children (Benjamin, Elizabeth, Gabriela, and Seraphina).

Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.

Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011.  She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA.  Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

Katherine Boyle, MD is an emergency medicine physician and medical toxicologist who recently took a position at Alnylam Pharmaceuticals as Director of Global Patient Safety & Risk Management. She was previously an attending at Beth Israel Deaconess Medical Center (BIDMC) and an Assistant Professor of Emergency Medicine at Harvard Medical School. At BIDMC, she was the Director of the Division of Medical Toxicology and Associate Director of Research for the Emergency Department. In addition, she was a faculty member for the Boston Children's Hospital medical toxicology fellowship and the MA/RI Poison Control Center.  She is a graduate of the University of Massachusetts Medical School where she stayed to complete her emergency medicine residency and medical toxicology fellowship.

Dr. Brandehoff is board certified in emergency medicine, medical toxicology, and addiction medicine with a focus on envenomation research. He has an appointment as Assistant Clinical Professor of Emergency Medicine at the University of Colorado School of Medicine and is faculty at the Rocky Mountain Poison and Drug Center. He is also the President and Medical Director for the Asclepius Snakebite Foundation, a 501(c)3 non-profit, that focuses on improving snakebite education and management in West Africa.

Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA.  She recently returned home to New Orleans, LA and is now working to develop a Medical Toxicology division at Ochsner Medical Center.  Professionally, she enjoys academics, perinatal toxicology, and health policy.  She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.

Dr. Peter R Chai is an assistant professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states.  Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.

Dr. Joshua (Josh) DeBord is a Senior Scientist at the CFSRE working in the areas of forensic toxicology and forensic chemistry. Dr. DeBord joined the CFSRE in early 2022 and performs R&D on challenging toxicological casework and profiles physical drug evidence on projects related to the CFSRE’s drug characterization initiatives, including CFSRE’s NPS Discovery program.

Dr. DeBord graduated with a B.S., M.S., and Ph.D., each in Chemistry, from Florida International University (FIU) in Miami, FL. Dr. DeBord’s doctoral research was conducted under the mentorship of Professor José Almirall on profiling and geographic provenance determination of heroin. Before joining CFSRE, Dr. DeBord was employed at the North Louisiana Crime Lab in Shreveport, LA, as a forensic chemist and toxicologist. Beginning there in 2018, Dr. DeBord and two colleagues started the toxicology section from only blood ethanol analysis to ISO/IEC 17025:2017 accreditation for qualitative determination and quantitative measurement of most drugs by March 2020. He also assisted with the development and implementation of the North Louisiana Crime Lab’s statistical sampling procedure to reduce backlog in the large-seizure drug casework. He continued to perform casework analysis and expert testimony before joining CFSRE in 2022.

Dr. DeBord is passionate about teaching, research, and mentorship. His research interests focus on applied research for increasing the capabilities of publicly funded forensic labs and improving the work experience for forensic professionals.

Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

Dr. Tharwat El Zahran is an Assistant Professor of Emergency Medicine and the Medical director for the emergency department at the American University of Beirut Medical Center (AUBMC)

She completed a fellowship training in medical toxicology at Emory University and CDC, and currently co-directs the medical toxicology service at AUBMC.

Dr. Brenna Farmer is Chief of Emergency Medicine at NY Presbyterian Brooklyn Methodist Hospital and Vice Chair in the Department of Emergency Medicine at Weill Cornell Medicine's Department of Emergency Medicine. She trained in Emergency Medicine at Vanderbilt University Medical Center and in toxicology at NYU/Bellevue and the New York City Poison Control Center. She earned her medical degree from East Carolina University's Brody School of Medicine and her executive MBA from Cornell and MS in Healthcare Leadership from Cornell's Weill Cornell Graduate School of Medical Sciences. Her major academic interests are medication safety, patient safety, and acute bedside care of the toxicologic patient.

Dr. Hendrickson is a Professor of Emergency Medicine and Medical Toxicologist at the Oregon Health and Science University (OHSU) in Portland, Oregon. He is the Program Director of the Fellowship in Medical Toxicology at OHSU and the Medical Director of the Oregon Poison Center, serving Oregon, Alaska, and Guam.

Dr. B. Zane Horowitz served as the medical director of the Oregon-Alaska-Guam Poison Center for 22 years. He also served as the medical director for the Utah Poison Control Center for 7 of those years. He currently continues to teach at Oregon Health and Science University in medical toxicology, and has authored over 90 publications.

Katherine Katzung, MD is an attending physician in the emergency department at Abbott Northwestern, where she serves as chair of the department.  Additionally, she is the medical director of the hospital’s addiction medicine and toxicology program, which began in 2020 after she received grant funding to initiate a hospital-based toxicology/addiction medicine consult service as well as an  emergency department-based addiction medicine "bridge" clinic to provide continuity of care for patients initiated on Suboxone.  This innovative program allows patients evaluated at Abbott Northwestern in the emergency department or inpatient units continuity of care, while focusing on harm-reduction strategies, until they can be given a warm hand-off to community providers.

A graduate of the University of Minnesota School of Medicine, she completed emergency medicine training at Regions Hospital in St. Paul and additional fellowship training in medical toxicology.  She is board certified in emergency medicine, medical toxicology, and addiction medicine.  Her clinical interests surround the intersection of these 3 specialties, with special focus on early ED & hospital-based interventions to evaluate and treat substance use disorder, including initiation of medication assisted therapies.

She volunteers as a consultant for the Minnesota Poison Control System in addition to serving on the board of the Steve Rummler HOPE Network and acts as medical director of its overdose prevention program.

Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html).

He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation.

As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).

JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Ophir Nelson is a Doctor of Medicine (MD)at the Rappaport Faculty of Medicine, Technion–Israel Institute of Technology. He is also a Board-Certified Expert in Internal Medicine, Clinical Pharmacology and Toxicology Chair, a Israel Society of Toxicology. Dr. Ophir serves on the Israel Medical Association as a Board member, and is a member of the European Association of Poisons Centres and Clinical Toxicologists. He is head of the Clinical Pharmacology and Toxicology Unit, Carmel Medical Center in Haifa, Israel. Dr. Ophir is a Clinical Senior Lecturer at the Rappaport Faculty of Medicine. He also serves as the Technion–Israel Institute of Technology Chair in the National Antidote Stockpiling Committee. Dr. Ophir additionally serves in the Israel Ministry of Health as a Board member, and is a member of the Israel Association for Clinical Pharmacology, Israel Medical Association Member, and the American College of Medical Toxicology. He is the Former Head, Patient Safety and Risk Management Unit, Carmel Medical Center in Haifa, Israel.

Dr. Lorenzo Leggio is a Senior Investigator in the NIH Intramural Research Program (IRP) with faculty appointments both at NIDA and NIAAA. He serves as Chief of the Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, a joint NIDA and NIAAA laboratory. He also serves as the NIDA Deputy Scientific Director, NIDA Acting Clinical Director, and Chief of the NIDA IRP Translational Addiction Medicine Branch. He also serves as a NIH Senior Attending Medical Staff and as senior medical advisor to the NIAAA Director. Dr. Leggio received his M.D. and Ph.D. from the Catholic University of Rome and ‘Agostino Gemelli’ hospital, where he also completed residency and received Board Certification in Internal Medicine. He was a visiting research associate, then postdoctoral research associate in Psychiatry and Human Behavior at Brown University, Providence, RI. In 2010, he joined the faculty of the Brown University Medical School as Assistant Professor at the Brown University Center for Alcohol and Addiction Studies, where he still holds an adjunct appointment as Professor in Behavioral and Social Sciences. He is also an Adjunct Professor of Addiction Medicine at Johns Hopkins University and Adjunct Professor of Neuroscience at Georgetown University. 

Dr. Leggio’s clinical research has been primarily focused on the treatment of alcohol and substance use disorders, with a special emphasis on the role of microbiome-gut-liver-brain and neuroendocrine pathways as well as GABAergic pathways; and on the medical consequences of alcohol use disorder, focusing on alcohol-associated liver disease. As a Principal Investigator at Brown University, Dr. Leggio received extramural research funding from NIAAA and NIDA, as well as from Brown University, the European Foundation for Alcohol Research, ABMRF/The Foundation for Alcohol Research, and the Brain and Behavior Research Foundation (NARSAD Young Investigator Award). At Brown University first, and at the NIH since 2012, Dr. Leggio, together with his team, colleagues and collaborators have pioneered and conducted work on medication development, on the role of the microbiome-gut-liver-brain axis and on the role of neuroendocrine pathways in addictive behaviors via human laboratory studies and clinical trials as well as via translational and reverse translational experimental medicine approaches. 

In 2022, Dr. Leggio was elected Fellow of the American College on Neuropsychopharmacology. Among other awards, Dr. Leggio received the 2008 Nordmann Award from the European Society for Biomedical Research on Alcoholism, the 2016 Early Career Investigator Award from the Research Society on Alcoholism, the 2018 Eva King Killam Award from the American College on Neuropsychopharmacology and the 2020 Jacob P. Waletzky Award from the Society for Neuroscience.

Michael Levine is a Los Angeles native, who completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine program, based out of Brigham and Women’s Hospital and Massachusetts General Hospital. After residency, he completed his medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. After staying as faculty for a year in Phoenix, he moved back to Los Angeles, where he joined the faculty at USC. He is currently the division chief of medical toxicology. He is actively involved in patient care, research, and serves on numerous hospital and university committees. He is an active member of American College of Emergency Physicians, the American College of Medical Toxicology, and is a member of the Toxicology Investigator's Consortium.

Ryan Marino, MD is a medical toxicologist, emergency physician and addiction medicine specialist in Cleveland, OH. He currently practices at University Hospitals Cleveland Medical Center, Cincinnati Children’s Hospital Drug and Poison Information Center, and is an Assistant Professor in the Departments of Emergency Medicine and Psychiatry at Case Western Reserve University School of Medicine. He is the Medical Director for the Toxicology & Addiction Bridge Clinic at University Hospitals Cleveland Medical Center. Outside of work he can often be found spending way too much time on social media.

Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Assistant Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Associate Medical Director for the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.

Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City.  She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the  “Tox in Ten” and “ ACMT Highlights” Podcast.

Mark Mycyk currently serves as Editor-in-Chief of Journal of Medical Toxicology and Chair of Research in the Department of Emergency Medicine at Cook County Health in Chicago.

Dr. Phillips is a graduate of Texas A&M University, Class of 2007, with a Bachelor’s in Biomedical Science.  He completed medical school at Texas Tech University School of Medicine in 2011 and attended the University of Pittsburgh for both residency in Emergency Medicine and fellowship in Medical Toxicology from 2011 – 2016.  Following graduation, he accepted a position at John Peter Smith in Fort Worth, Texas where he served as their Assistant Program Director for the Emergency Medicine residency program and founded the inaugural Division of Medical Toxicology.  Dr. Phillips then transitioned to University of Texas Southwestern in Dallas, Texas where he served as the Program Director of the Medical Toxicology Fellowship. Dr. Phillips is looking forward to his upcoming transition to Director of Toxicology for Integrative Emergency Services in Dallas/Fort Worth. His professional interests include medical education, medical toxicology advocacy, and alcohol withdrawal. 

Matthew Salzman received his Bachelor of Arts in Music from the University of Rochester and his Medical Degree from the Sidney Kimmel Medical College at Thomas Jefferson University.  He trained in Emergency Medicine and Medical Toxicology at Drexel University College of Medicine.  Currently, he is an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology and Addiction Medicine at Cooper Medical School of Rowan University.  He is the Medical Director for the In-patient Addiction Medicine Consult service as well as Medical Director for Research for Addiction Medicine at Cooper.  He is also a volunteer consultant in toxicology for the Children's Hospital of Philadelphia and the Philadelphia Poison Control Center.

Andrew Stolbach is currently Chair of the American Board of Emergency Medicine (ABEM) Medical Toxicology Subboard. ABEM writes and administers board certification materials including MyToxCert.

Jeffrey Suchard is an Emergency Physician and Medical Toxicologist at the University of California, Irvine.  After undergraduate studies in Biochemistry at UC Berkeley, he attended medical school at UCLA, EM residency at UConn, then completed medical toxicology fellowship in Phoenix, AZ.  Dr. Suchard has worked clinically at UC Irvine since 1999 and began his current involvement in medical student education in 2010.  He teaches Epidemiology & Biostatistics to the MS1 class (since 2010), is the course director for MS2 Medical Pharmacology (since 2011), and serves as Associate Dean for Basic Science Education (since 2014).

Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.

Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.

Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center.

Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.

James Watson is a board certified medical toxicologist and emergency medicine physician practicing at Maine Medical Center and the Northern New England Poison Center, and is an Assistant Professor in the Department of Emergency Medicine at Tufts University School of Medicine. James graduated from the University of Chicago Pritzker School of Medicine in 2017 before completing residency training at the Harvard Affiliated Emergency Medicine Residency at Beth Israel Deaconess Medical Center and fellowship training at the Harvard Medical Toxicology Program at Boston Children’s Hospital; both in Boston, Massachusetts. His academic interests include medical education, resource utilization within medical toxicology, and critical care toxicology. James is a Portland native, and lives in Southern Maine with his wife, son, and rescue dog Mowgli.

James Whitledge, MD is a Medical Toxicology Fellow at Boston Children's Hospital in Boston, MA. He is also an Emergency Physician at Beth Israel Deaconess Medical Center Boston, MA. In his free time he also is the current Co-Chair of the AACT Herbs & Dietary Supplements Section.

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

Dr. Alan D. Woolf is a pediatrician and medical toxicologist. He is the Associate Chief Medical Education Officer at Boston Children’s Hospital and a Professor of Pediatrics at Harvard Medical School. He is Medical Director of the Pediatric Environmental Health Center at Boston Children’s Hospital, Director of the Pediatric Environmental Health Fellowship Training Program, and Principal Investigator of the Region 1 New England Pediatric Environmental Health Specialty Unit. He is currently a member of the Executive Committee of the American Academy of Pediatrics’ Council on Environmental Health & Climate Change and a member of the PFAS Subcommittee of the National PEHSU Program. Dr. Woolf has served as a consultant regarding PFAS water contamination to both the New Hampshire and Massachusetts Departments of Public Health since 2014. He co-authored one of the first papers to describe the PFAS water contamination event in Portsmouth NH and was a ‘Community Liaison’ giving input to the NASEM Report on PFAS published in 2022. He is currently a member of the New Hampshire State Advisory Committee on PFAS and cancer. 

Dr. Woolf is a past-president of both the American Academy of Clinical Toxicology and the American Association of Poison Control Centers. In 2018, Dr. Woolf received the Career Achievement Award from the AACT and, in 2019, he was named the Louis Roche Lecturer by the European Association of Poisons Centers and Clinical Toxicologists. He is the Editor of the recent book The History of Modern Clinical Toxicology published by Elsevier Publishers in 2021.

Nasim Zamani graduated from Azad University of Medical Sciences in Tehran, Iran in 2004. She started residency in Forensic Medicine and Clinical Toxicology in 2008 and finished the course with the first rank of the national board followed by fellowship program in clinical toxicology in Loghman Hakim Hospital- one of the largest in-patient clinical toxicology centers in the world- in affiliation with Shahid Beheshti University of Medical Sciences. After graduation, She started to work in the same setting as attending physician in 2014 where she was responsible for patient treatment, teaching, and research in the field. She has won three international grants in the field of clinical toxicology and is currently a board member of APAMT and a member of EAPCCT.

Dr. Matt Zuckerman is an medical toxicologist at the University of Colorado Anschutz Medical Campus and Rocky Mountain Poison & Drug Safety. He is the pharmacology content director for the CU School of Medicine curriculum.

Dr. Elizabeth Ballard is the Director of Psychology and Behavior Research and the Director of Predoctoral Training at the Experimental Therapeutics and Pathophysiology Branch in the National Institute of Mental Health.  She is trained as a clinical psychologist from the Catholic University of America and has extensive clinical experience working with suicidal patients.  She completed her predoctoral internship at the Department of Veterans Affairs Eastern Colorado Health Care System and a postdoctoral fellowship at Johns Hopkins School of Medicine. As an associate scientist, she is the Lead Associate Investigator on the Neurobiology of Suicide Protocol in the Intramural Program of the NIMH.  She has published over 95 articles and her research interests include short term risk factors for suicide and rapid acting treatments for suicidal thoughts.

Dr. Campman is San Diego County’s Chief Medical Examiner.  He earned his B.S. in Biology from Loyola Marymount University in 1987; graduated from Creighton University School of Medicine in Omaha, in 1992, and then completed residency in Anatomic and Clinical Pathology at the University of California, Davis Medical Center, in 1997.  Following fellowship training in Forensic Pathology with the Northern California Forensic Pathology Group at the Sacramento County Coroner’s Office in 1998, he went to work for the US Air Force and was stationed at the Office of the Armed Forces Medical Examiner, the Armed Forces Institute of Pathology, in Washington DC, as Associate, then Deputy and Chief Deputy Medical Examiner for Medicolegal Operations and Investigations, until he went to work for the County in 2001 (later continuing to serve in the Air Force Reserve as a Regional Medical Examiner until he retired).  He is Board Certified in Anatomical/Clinical, and Forensic Pathology, and leads the Medical Examiner’s Department while continuing to regularly perform autopsies, and testify in CA Superior Court.

Professor Carter is currently the Senior Staff Specialist and Acting Director of Dept. Consultation Liaison Psychiatry, Calvary Mater Newcastle Hospital, Waratah; and Conjoint Professor in Psychiatry in the College of Health, Medicine and Wellbeing, School of Medicine and Public Health, University of Newcastle. He is a Chief Investigator for the NHMRC Centre of Research Excellence in Suicide Prevention (CRESP 2.0). He is the Chair for the RANZCP for the Clinical Practice Guidelines for Deliberate Self-Harm, a member of the Presidents Suicide Advisory Committee and the RANZCP representative to the Prime Minister’s Suicide Advisory Group.

Current areas of clinical and research interest include; deliberate self-poisoning, suicide prevention, epidemiology of suicidal behaviours, delirium, screening for depression, somatisation, organ donation and psycho-oncology.

Andrew Dawson is an Australian Clinical Pharmacologist and Toxicologist whose major interest is in translational clinical toxicology research to produce changes in policy and clinical practice.

He established the Australian Hunter Area Toxicology Service in Newcastle in 1987, research included interventions for deliberate self-harm, relative toxicity of drugs in overdose and prediction of toxicity.

In 2004 he moved to Sri Lanka to establish the South Asian Clinical Toxicology Research Collaboration. This group built sustainable research capacity addressing deliberate self-harm with pesticides and improved clinical practice in resource poor settings. This research contributed to policy that reduced Sri Lankan national suicide deaths by 50%

In 2010 he returned to Australia and became the Director of Clinical Toxicology Royal Prince Alfred Hospital, and the Director of the New South Wales Poison Information Centre (to 2021) at the Childrens Hospital Westmead. He is Clinical Professor Medicine, University of Sydney and Adjunct Professor School of Medicine University of NSW. Current interests include management of institutional responses to patients with challenging self-harm behaviours, substance use disorder and self-harm, evaluating the effects of regulatory changes on incidence of deliberate self-harm.

My work’s major aim is to reduce deaths from pesticide and plant self-poisoning in rural Asia, a cause of over 200,000 premature deaths each year and a key global means of suicide. To do this, I perform clinical trials in South Asian district hospitals to better understand the pharmacology and effectiveness of antidotes and community-based controlled trials to identify effective public health interventions. This work is complemented by translational studies of antidotes in minipig models of poisoning in a large animal critical care laboratory that I established in Edinburgh, work with sociologists and anthropologists to better under-stand the meaning of self-harm, and work with the WHO and FAO to aid implementation. I work with pesticide regulators through the Centre for Pesticide Suicide Prevention. I also perform clinical and animal research in Edinburgh to improve treatment of other forms of poisoning (such as from cyanide, alcohol, and contrast media) by developing and/or testing novel antidotes.

Dr. Tharwat El Zahran is an Assistant Professor of Emergency Medicine and the Medical director for the emergency department at the American University of Beirut Medical Center (AUBMC)

She completed a fellowship training in medical toxicology at Emory University and CDC, and currently co-directs the medical toxicology service at AUBMC.

Dr. Finkelstein is a Professor of Pediatrics, Pharmacology and Toxicology, University of Toronto and a Senior Clinician-Scientist at The Hospital for Sick Children. 

He holds the Canada Research Chair in Pediatric Drug Safety and Efficacy (Tier I). Dr. Finkelstein is triple-trained in medical toxicology, clinical pharmacology and pediatric emergency medicine. Since 2016, he has served as a “Thought Leader” for NIH’s Pediatric Trials Network, an alliance of >200 hospitals, working for drug label modifications for children at FDA. He also established and leads the ACMT Pediatric Marijuana & Opioids (PEDMOP) Toxicology Investigators Consortium (ToxIC) sub-registries.

The overarching goal of his research program focuses on optimizing therapeutics and outcomes of sick and injured children in acute care settings and prevention of accidental and intentional drug overdose and subsequent suicide, employing epidemiological, randomized clinical trials and precision tools.

Michael Holland is the  Director of Occupational Medicine for the Saratoga Hospital Medical Group, Saratoga Hospital Employee Health Medical Director,  Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY,  Consulting Medical Toxicologist at the Upstate New York Poison Center and at the Onondaga County Medical Examiner’s Office-both in Syracuse, NY, and Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.  Dr. Holland has ABMS Board Certifications in Occupational Medicine, Medical Toxicology, Emergency Medicine, and Addiction Medicine.

Filza Hussain, MD, is a Clinical Associate Professor of Psychiatry at Stanford University School of Medicine. She attended medical school in Pakistan and completed her residency training at the Mayo Clinic, Minnesota and a Consultation Liaison Psychiatry fellowship at Columbia University in New York. Her clinical focus is transplant psychiatry and she serves as the liaison to the Liver and Kidney transplant programs at Stanford. Other areas of clinical/research interests include Personality disorders, Suicidology, Cultural Psychiatry, and medical pedagogy.

Dr. Klotz received his undergraduate degree from the University of Southern California in International Relations, his medical degree from the Uniformed Services University of the Health Sciences, and completed his residency in Psychiatry at Naval Medical Center San Diego. He is a member of the Gold Humanism and Alpha Omega Alpha honor societies. He is currently the embedded psychiatric provider for the 5th Marine Regiment in San Clemente California.

Larissa Laskowski is a clinical assistant professor and medical toxicologist at NYU Grossman School of Medicine, and serves as a consultant for the New York City Poison Control Center. She is also cofounder and director of The Prevention Education Partnership (PEP), an initiative dedicated to decreasing the incidence of preventable illness and injury commonly seen in the emergency department. Through PEP Talks, a harm-reduction drug education curriculum, she deploys doctors into local schools to educate middle and high school students, teachers, and parents, in an effort to keep NYC youth safe, healthy, and out of the ER. Due to the rapidly evolving threat of teen fentanyl overdose, she is currently laser-focused on ensuring that every student, teacher, and parent knows how to recognize an opioid overdose and save a life by administering naloxone. 

She currently resides in Manhattan with her husband Mike and two small children Frida and Miles.

Bruno Mégarbane is Professor of critical care medicine at Paris University and directs a research team at INSERM UMRS-1144. He is the Head of the Department of Medical and Toxicological Critical Care at Lariboisière Hospital, Paris, France. He conducted several clinical and experimental studies in clinical toxicology.

Dr. Rasimas attended the University of Scranton and graduated summa cum laude with degrees in biochemistry, mathematics, and philosophy. He completed the Medical Scientist Training Program at Penn State University, earning a Ph.D. in chemical biology (2002) and M.D. (2003). Upon graduation from the Penn State College of Medicine, Dr. Rasimas matriculated to psychiatry residency training at the Mayo Clinic in Rochester, Minnesota. He was a clinical fellow at the NIMH, training in consultation-liaison psychiatry, bioethics, and clinical research. Dr. Rasimas has studied psychoanalytic psychotherapy at the Minnesota Psychoanalytic Society and Institute and the Washington School of Psychiatry. He served as a C-L psychiatrist for Milton S. Hershey Medical Center and remains an Associate Professor of Psychiatry and Emergency Medicine for the Penn State College of Medicine, there. He completed the critical care based medical toxicology fellowship at Penn State, obtained board certification in addiction medicine, and then returned to NIMH to join the Undiagnosed Diseases Program and the Intramural Research Program to oversee clinical trials in mood and anxiety disorders. He is also a Fellow of the Academy of Psychosomatic Medicine and a Laughlin Fellow with membership in the American College of Psychiatrists. Dr. Rasimas is a Professor at the University of Minnesota, pursuing an academic medical career at the interface of psychosomatic medicine, medical toxicology, and psychodynamic psychotherapy with a primary clinical interest in the phenomenology of suicide. His current clinical position is the director of Consultation-Liaison Psychiatry services for the Queen Elizabeth Hospital in Charlottetown, Prince Edward Island.

CAPT Joshua G Schier, MD MPH was appointed the 9th Chief Professional Officer of the Medical Category of the Commissioned Corps of the U.S. Public Health Service (Corps) in November 2021. As the Chief Medical Officer, CAPT Schier provides leadership and direction for Corps medical officers and advises the Office of the Surgeon General and the Department of Health and Human Services (HHS) on recruitment, assignment, deployment, retention, and career development of Corps physicians. CAPT Schier is currently assigned to the CDC's National Center for Injury Prevention and Control (NCIPC), Division of Overdose Prevention (DOP) as a Senior Medical Officer. At CDC, he serves as a Strategy Lead for CDC’s Overdose Data to Action Program overseeing activities related to linking overdose patients to care and supporting providers and health systems across 66 states, counties, and metropolitan areas. He is the CDC/ATSDR Site Director for the joint Emory/CDC Medical Toxicology Fellowship and serves as a subject matter expert for CDC in Medical Toxicology for informing various activities related to stimulants and other drugs of abuse. CAPT Schier spent 15 years at CDC’s National Center for Environmental Health, where he oversaw national real-time surveillance activities for poisoning events via PCC data, radiation disaster preparedness activities, and provided expert clinical consultation for suspected and known domestic and international mass poisoning incidents. He served two terms on ABEM’s Medical Toxicology Sub-Board and has published more than 75 articles in peer-reviewed journals and CDC’s Morbidity and Mortality Weekly Report.

Dominic Sisti, PhD, is an associate professor in the Department of Medical Ethics & Health Policy at the University of Pennsylvania. He directs the Scattergood Program for the Applied Ethics of Behavioral Health Care and holds secondary appointments in the Department of Psychiatry, where he directs the ethics curriculum in the residency program, and the Department of Philosophy. Dr. Sisti examines ethical and policy challenges in mental health care, including long-term psychiatric care for individuals with serious mental illness and clinical ethics issues in correctional settings. Sisti's research also explores ethical issues in psychedelic research and clinical application.

Dr Akpunonu is an associate professor of emergency medicine and medical toxicology at the University of Kentucky. His professional interests are CBRNE, novel psychoactive substances and health disaparities in poisoning. He enjoys hands on practical lectures. He has participated in multiple clinical trials and is an active member of MENATOX, ACMT and AAEM Dr Akpunonu is the medical director of the inpatient toxicology consultation service at the University of Kentucky. He also is the medical director of the Undersea and Hyperbaric Medicine service. Dr Akpunonu is also the medical director of the Kentucky Poison Control Center. 

 As an emergency physician and toxicologist, Dr. Akpunonu specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of novel psychoactive substances of abuse, envenomations and prescribed patterns.

Dr. Druck went to medical school at Baylor College of Medicine, followed by residency at Denver Health.  He currently serves as the Vice Chair of Faculty Advancement, DEI, and Wellbeing for the Department of Emergency Medicine at the University of Utah, as well as serving on the board of SAEM. His interests include mentorship, wellbeing, diversity, equity and inclusion (DEI), medical education, and the intersection of education and clinical care. He has been involved in medical education at the undergraduate level, graduate level, and CME level.  From a DEI perspective, he has been involved in DEI efforts on an undergraduate, graduate, and national level.

Research interests: mentoring, medical education, wellbeing, DEI

Dr. Kevin Mercer is originally from Louisville, KY. He received PharmD and MPH degrees from the University of Kentucky and pursued pharmacy residency training at The University of Chicago Medicine and The Johns Hopkins Hospital. His professional interests within the realm of emergency medicine include toxicology, cardiac arrest, and global health. In his spare time, he enjoys traveling, SCUBA diving, and cooking.

Adam is the managing director of the Indiana Poison Center. After earning his PharmD from UNC in 2010, he practiced in a variety of settings before finding a home in the world of toxicology and poison centers. He is a Diplomate of ABAT and is active on multiple committees through ABAT, AACT, America’s Poison Centers, and other organizations, and maintains an active precepting schedule for two schools of pharmacy and numerous PGY1 and PGY2 pharmacy residency programs. His interests include acetaminophen poisoning, novel psychoactive substances, and institutional and organizational psychology, but what he loves most of all is spending every minute he can with his "threenager" and wife, collecting and using fountain pens, and watching soccer.

Dr. Justin Seltzer was born and raised in San Diego, CA. He did both his undergraduate studies and medical school at the University of Southern California in Los Angeles, CA. He completed residency training in emergency medicine at Northwestern University in Chicago, IL. Within toxicology, his interests include pharmaceutical drug toxicity, antidote development and drug repurposing, and hazardous materials such as chemical warfare agents, pesticides, industrial chemicals, and radiation exposure.

Haylee Veazey is a faculty physician who is dual board certified in Emergency Medicine and Internal Medicine. She practices at Hennepin County Medical Center in Minneapolis and is an Assistant Professor in both EM and IM at the University of Minnesota School of medicine. She is the medical director of the Adult Gender and Sexual Health clinic at Hennepin Healthcare and splits her time evenly between Gender and Sexual Health and Emergency Medicine.  She came out of the closet as a trans woman early in her residency and has been active in educating on diversity and gender and sexual health since then.

Garry Winkler, M.D. is a Board Certified Medical Toxicologist and Emergency Medicine physician based out of Houston, Texas. He is at the University of Texas Health Houston practicing Emergency Medicine and Toxicology and is the Section Chief of Medical Toxicology. Garry serves as the current co-chair for the American Academy of Clinical Toxicology’s (AACT) Diversity, Inclusion, and Equity section.

He graduated from Trinity University in San Antonio, Texas with a Bachelor of Science in Biochemistry and Molecular Biology in 2008. After receiving his Medical Degree at the University of Texas Health Science Center in San Antonio, he completed his Surgical Internship at Boston Medical Center in Boston, MA. He completed his Emergency Medicine Residency at the University of Arizona Tucson University Campus and received a distinction in Medical Education. He completed his Medical Toxicology fellowship at the University of California San Diego.

Michael Yeh, MD, MS, is a medical officer at the National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia, and a Lieutenant Commander in the U.S. Public Health Service Commissioned Corps. Michael obtained a B.S. in biology from SUNY Stony Brook, an M.S. in journalism from Columbia University, as well as an M.S. in epidemiology and M.D. from the University at Buffalo. He completed a combined internal medicine / emergency medicine residency at Allegheny General Hospital in Pittsburgh. Michael worked as an emergency physician in community hospitals on Long Island and Rhode Island before completing the Emory University/CDC fellowship in medical toxicology in 2021. His current activities at CDC include working with America’s Poison Centers on surveillance of chemical exposures and public health hazards, acute outbreak investigations, emergency preparedness for chemical and radiological disasters, and medical toxicology fellow education.